270 related articles for article (PubMed ID: 24629500)
1. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
Patel HD; Kates M; Pierorazio PM; Allaf ME
Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
[TBL] [Abstract][Full Text] [Related]
2. The effect of race and gender on the surgical management of the small renal mass.
Kates M; Whalen MJ; Badalato GM; McKiernan JM
Urol Oncol; 2013 Nov; 31(8):1794-9. PubMed ID: 22687567
[TBL] [Abstract][Full Text] [Related]
3. Balancing cardiovascular (CV) and cancer death among patients with small renal masses: modification by CV risk.
Patel HD; Kates M; Pierorazio PM; Allaf ME
BJU Int; 2015 Jan; 115(1):58-64. PubMed ID: 24589376
[TBL] [Abstract][Full Text] [Related]
4. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
5. Disparities in treatment and outcome for renal cell cancer among older black and white patients.
Berndt SI; Carter HB; Schoenberg MP; Newschaffer CJ
J Clin Oncol; 2007 Aug; 25(24):3589-95. PubMed ID: 17704406
[TBL] [Abstract][Full Text] [Related]
6. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
7. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice.
Wang DC; Plante K; Stewart T; Wang D; Formica M; Daugherty M; Bratslavsky G
Urol Oncol; 2017 Nov; 35(11):660.e9-660.e15. PubMed ID: 28736248
[TBL] [Abstract][Full Text] [Related]
8. Race affects access to nephrectomy but not survival in renal cell carcinoma.
Zini L; Perrotte P; Capitanio U; Jeldres C; Duclos A; Arjane P; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
BJU Int; 2009 Apr; 103(7):889-93. PubMed ID: 19021607
[TBL] [Abstract][Full Text] [Related]
9. Sociodemographic disparities in the treatment of small renal masses.
Becker A; Roghmann F; Trinh QD; Hansen J; Tian Z; Shariat SF; Noldus J; Perrotte P; Graefen M; Karakiewicz PI; Sun M
BJU Int; 2013 Jun; 111(8):E274-82. PubMed ID: 23714645
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B
Cancer Med; 2016 Aug; 5(8):2101-8. PubMed ID: 27228559
[TBL] [Abstract][Full Text] [Related]
12. Overall survival advantage with partial nephrectomy: a bias of observational data?
Shuch B; Hanley J; Lai J; Vourganti S; Kim SP; Setodji CM; Dick AW; Chow WH; Saigal C;
Cancer; 2013 Aug; 119(16):2981-9. PubMed ID: 23674264
[TBL] [Abstract][Full Text] [Related]
13. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
14. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN
Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041
[TBL] [Abstract][Full Text] [Related]
15. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
16. Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era.
Culp SH; Karam JA; Wood CG
Urol Oncol; 2014 Jul; 32(5):561-8. PubMed ID: 24709415
[TBL] [Abstract][Full Text] [Related]
17. Life Expectancy and Variation in Treatment for Early Stage Kidney Cancer.
Daskivich TJ; Tan HJ; Litwin MS; Hu JC
J Urol; 2016 Sep; 196(3):672-7. PubMed ID: 27012644
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
19. Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: a population-based evaluation.
Bianchi M; Becker A; Abdollah F; Trinh QD; Hansen J; Tian Z; Shariat SF; Perrotte P; Karakiewicz PI; Sun M
Int J Urol; 2013 Nov; 20(11):1064-71. PubMed ID: 23418921
[TBL] [Abstract][Full Text] [Related]
20. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
